A.R.T. Advisors’s Usana Health Sciences USNA Stock Holding History

A.R.T. Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,696	Closed	-$390K	–	1745
2019 Q3	$390K	Sell	5,696 -15,800	-74%	-$1.06M	0.02%	950
2019 Q2	$1.71M	Sell	21,496 -1,400	-6%	-$111K	0.1%	277
2019 Q1	$1.92M	Buy	22,896 +16,600	+264%	+$1.73M	0.11%	251
2018 Q4	$741K	Sell	6,296 -10,900	-63%	-$1.26M	0.05%	550
2018 Q3	$2.07M	Buy	17,196 +7,100	+70%	+$881K	0.09%	281
2018 Q2	$1.16M	Buy	+10,096	New	+$1.1M	0.05%	571
2017 Q2	–	Sell	-13,876	Closed	-$799K	–	1738
2017 Q1	$799K	Buy	+13,876	New	+$828K	0.04%	638
2015 Q3	–	Sell	-5,238	Closed	-$357K	–	1607
2015 Q2	$357K	Buy	+5,238	New	+$332K	0.01%	1121
2015 Q1	–	Sell	-21,286	Closed	-$1.09M	–	1707
2014 Q4	$1.09M	Buy	+21,286	New	+$1.05M	0.04%	613

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's USNA Position: Q4 2019 in Review

A.R.T. Advisors sold out of Usana Health Sciences (USNA) in Q4 2019, closing a stake of 5,696 shares — an estimated $390K sold.

A.R.T. Advisors first reported a position in USNA in Q4 2014 and held it in 9 quarters. The position peaked at $2.07M in Q3 2018. 175 funds tracked by Wall St. Rank hold USNA as of Q4 2019.

A.R.T. Advisors reported no remaining Usana Health Sciences position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 5,696 Usana Health Sciences shares in Q4 2019, an estimated $390K.
A.R.T. Advisors first reported a position in Usana Health Sciences in Q4 2014 and held it in 9 quarters.
A.R.T. Advisors's Usana Health Sciences position peaked at $2.07M in Q3 2018.
175 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.